Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

duocarmycin SA MeSH Supplementary Concept Data 2025


MeSH Supplementary
duocarmycin SA
Unique ID
C066098
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C066098
Entry Term(s)
(+)-duocarmycin SA
Cyclopropa(c)pyrrolo(3,2-e)indole-6-carboxylic acid, 1,2,4,5,8,8a-hexahydro-4-oxo-2-((5,6,7-trimethoxy-1H-indol-2-yl)carbonyl)-, methyl ester, (7bR)-
Pharm Action
Antibiotics, Antineoplastic
Antineoplastic Agents, Alkylating
Registry Numbers
130288-24-3
Previous Indexing
Indoles (2004-2019)
Pyrroles (2004-2019)
Heading Mapped to
*Duocarmycins
Frequency
73
Note
structure similar to CC-1065 and yatakemycin, composed of a pyrrolo-indole plus an indole; isolated from Streptomyces
Source
J Antibiot (Tokyo) 1990;43(8):1037
Date of Entry
1990/11/16
Revision Date
2019/05/17
duocarmycin SA Preferred
(+)-duocarmycin SA Narrower
page delivered in 0.004s